REM Sleep Atonia Control Failure Module

Neuroscience Module rem_sleep_atonia_control_failure 1 disorder Pathograph 7

A conserved brainstem-circuit mechanism module for failure of the skeletal muscle atonia that normally accompanies REM sleep. REM sleep is generated by a mutually inhibitory pontine flip-flop switch, and the REM-on side contains two anatomically separate glutamatergic output populations: one ascending to the basal forebrain, which produces the EEG features of REM sleep, and one descending from the sublaterodorsal nucleus to ventromedial medullary and spinal inhibitory premotor neurons, which produces atonia. Because the two outputs are independent, they can fail independently - and that dissociability is the anatomical fact this module exists to record. Degeneration or lesion of the descending limb leaves REM sleep otherwise intact while removing its paralysis, so motor programmes generated during dreaming reach the muscles: REM sleep without atonia, then dream enactment, then injury. In older adults the commonest cause of that degeneration is an evolving synucleinopathy, which makes the syndrome a prodromal marker as well as a parasomnia.

⚙

Pathophysiology Nodes

5 shared nodes are defined in this module.

◉

Cell Types

⇄

Biological Processes

glutamatergic synaptic transmission GO:0035249 DECREASED inhibitory regulation of skeletal motor neuron output GO:0006937 DECREASED REM sleep GO:0042747 ABNORMAL skeletal muscle contraction during REM sleep GO:0003009 INCREASED muscle contraction GO:0006936 INCREASED

Notes

This is a mechanism module, not a specific disease. Disorder entries reference individual nodes via conforms_to (e.g. "rem_sleep_atonia_control_failure#Failure of REM Sleep Skeletal Muscle Atonia", the key conformance target and rate-limiting step). WHAT CONFORMANCE REQUIRES. Polysomnographically demonstrated REM sleep without atonia is the entry requirement, and it is a specific measurement - excess tonic or phasic chin (with or without limb) electromyographic activity scored during REM sleep. Nocturnal motor behaviour alone does not qualify and must not be conformed here, because the differential is exactly what this module distinguishes: NREM parasomnias (sleepwalking, confusional arousals) arise from incomplete arousal out of slow-wave sleep with atonia never having been engaged, and nocturnal frontal-lobe/sleep-related hypermotor seizures are epileptic. Both produce complex nocturnal movement with a fully intact atonia circuit. THE OPPOSITE FAILURE OF THE SAME CIRCUIT. Cataplexy is this machinery intruding into wakefulness; REM sleep behaviour disorder is the same machinery failing during REM sleep. Narcolepsy type 1 has both, which is not a paradox but a consequence of losing the orexinergic input that holds the switch stable. A narcolepsy entry curating both should conform to this module for the atonia failure and to orexin_arousal_instability for the state instability, rather than blending them - the modules make different claims and are separately falsifiable. TWO AETIOLOGICAL ROUTES, ONE MECHANISM. The degenerative route (alpha-synuclein pathology reaching the pontine atonia circuit, ahead of the nigrostriatal and cortical involvement that defines the overt disease) and the pharmacological route (serotonergic and noradrenergic antidepressants, which unmask or induce REM sleep without atonia) converge on the same central node. A conforming entry should say which it evidences, because only the first carries prodromal significance. TREATMENT PATTERN IS SYMPTOMATIC, AND SAYING SO IS THE POINT. Clonazepam and melatonin act on the effector node - they suppress the behaviours and reduce injury - and do not act on the trigger. Nothing available modifies the underlying degeneration, and a conforming entry must not present behavioural control as disease modification. The AASM recommendations for both agents are CONDITIONAL, not strong. SCOPE BOUNDARIES. Distinct from parkinsonism_dopaminergic_degeneration, which models the nigrostriatal arm of the same underlying synucleinopathy at a different site and a later stage; an entry may conform to both, and their temporal separation is the clinically useful part. Not an Xogenesis module - a normal inhibitory process fails, nothing pathological is formed (the alpha-synuclein aggregate itself belongs to amyloidogenesis and the synucleinopathy entries).

Discussions and Knowledge Gaps

Does the degree of REM sleep without atonia measure the extent of the pontine lesion, or the stage of the wider synucleinopathy?

KNOWLEDGE GAP gap_rswa_severity_versus_prodromal_stage

Attached to: Failure of REM Sleep Skeletal Muscle Atonia Injury Risk and Prodromal Neurodegeneration

Quantified atonia loss predicts phenoconversion, but the module's own anatomy offers two incompatible readings of why. If it measures the local pontine lesion, it should saturate once that nucleus is lost and stop tracking progression elsewhere; if it indexes the overall synuclein burden, it should keep rising as pathology spreads rostrally. The two predict different things about its value as a trial stratification and progression marker, and current cohorts have not separated them because atonia loss is almost always measured cross-sectionally at enrolment.

Proposed experiments: Serial atonia quantification against independent progression markers

Is antidepressant-associated REM sleep without atonia an independent pharmacological effect, or unmasking of an existing prodromal lesion?

KNOWLEDGE GAP gap_antidepressant_induced_rswa_significance

Attached to: Lesion of the Pontine REM-Atonia Generator

The module treats the pharmacological and degenerative routes to the trigger node as distinct, and instructs that only the degenerative one carries prodromal significance. That instruction is only safe if the two routes are genuinely separable. Serotonergic and noradrenergic antidepressants demonstrably increase REM electromyographic activity, but patients who develop the syndrome on antidepressants also convert to synucleinopathy at rates above the background, which is compatible with the drug lowering the threshold for a lesion that was already present. Until this is resolved, curators should record antidepressant exposure rather than treating it as an explanation that excludes the degenerative route.

Proposed experiments: Prospective follow-up of antidepressant-associated atonia loss

↗

Used By Disorder Entries

REM Sleep Behavior Disorder via Alpha-Synuclein Pathology in the Brainstem REM-Atonia Circuit → Lesion of the Pontine REM-Atonia Generator , Loss of Descending Drive to Inhibitory Premotor Neurons → Loss of Descending Glutamatergic Drive to Inhibitory Premotor Neurons , REM Sleep Without Atonia → Failure of REM Sleep Skeletal Muscle Atonia , Dream Enactment Behaviour → Motor Enactment of Dream Content During REM Sleep

⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence-backed metadata.

⚙

Pathophysiology

Lesion of the Pontine REM-Atonia Generator

trigger

The trigger is loss of function of the REM-on glutamatergic neurons of the sublaterodorsal nucleus (the rodent term; subcoeruleus in cat, and the homologous region in humans) or of their descending projection. Human evidence comes from the small number of cases in which structural brainstem lesions produce the syndrome, and consistently implicates the dorsal midbrain and pons. In the far commoner age-related form the lesion is degenerative rather than structural: alpha-synuclein pathology involving the pontine tegmentum, at a Braak stage that precedes nigral and cortical involvement. Conforming disorder nodes substitute the disorder-specific lesion - evolving synucleinopathy, a structural pontine lesion (stroke, demyelination, tumour), the orexin-deficiency-associated instability of narcolepsy type 1, or antidepressant exposure.

glutamatergic REM-on neuron of the sublaterodorsal nucleus CL:0000540 DECREASED

Used by disorders

REM Sleep Behavior Disorder as Alpha-Synuclein Pathology in the Brainstem REM-Atonia Circuit

Downstream

Loss of Descending Glutamatergic Drive to Inhibitory Premotor Neurons Loss of the REM-on population removes the excitatory drive its descending axons carry to medullary and spinal inhibitory premotor neurons.

Loss of Descending Glutamatergic Drive to Inhibitory Premotor Neurons

amplifier

Atonia is not a passive withdrawal of excitation but an active inhibition: the descending glutamatergic limb excites glycinergic and GABAergic premotor neurons in the ventromedial medulla and spinal cord, which hyperpolarise skeletal motor neurons. Losing the drive therefore releases motor neurons from an inhibition that should be present, rather than merely failing to quiet them. This node is where the module's central anatomical claim sits: this descending pathway is separate from the ascending pathway that generates the EEG features of REM sleep, so it can be lost while REM sleep itself continues normally.

glutamatergic synaptic transmission GO:0035249 DECREASED inhibitory regulation of skeletal motor neuron output GO:0006937 DECREASED

Used by disorders

REM Sleep Behavior Disorder as Loss of Descending Drive to Inhibitory Premotor Neurons

Downstream

Failure of REM Sleep Skeletal Muscle Atonia Without descending excitation of the inhibitory premotor pool, skeletal motor neurons are not hyperpolarised during REM sleep and muscle tone persists.

Failure of REM Sleep Skeletal Muscle Atonia

central effector

The rate-limiting, disorder-agnostic node and the key conformance target, measurable as REM sleep without atonia: excess tonic or phasic electromyographic activity during scored REM sleep. It is a graded and quantifiable trait rather than a binary one, which matters clinically - quantified atonia loss is itself a predictor of progression in the degenerative form. Crucially, this node is separable from the clinical behaviours below it: REM sleep without atonia can be present without dream enactment, and a conforming entry should say which of the two it is evidencing, since only the electrophysiological finding is required for conformance.

REM sleep GO:0042747 ABNORMAL skeletal muscle contraction during REM sleep GO:0003009 INCREASED

Used by disorders

REM Sleep Behavior Disorder as REM Sleep Without Atonia

Downstream

Motor Enactment of Dream Content During REM Sleep With motor neurons no longer inhibited, the motor programmes generated during REM dreaming are executed rather than suppressed.

Motor Enactment of Dream Content During REM Sleep

effector

Released motor output takes the form of behaviour matched to dream content rather than random movement, which is the observation that ties the node to REM physiology rather than to a nonspecific motor release. Because REM dream content in this population is disproportionately confrontational, the behaviours are frequently violent - punching, kicking, leaping from bed - and the injury risk falls on both patient and bed partner. Movements are not preceded by the confusional arousal typical of an NREM parasomnia, and patients wake alert with dream recall, which is the bedside discriminator.

muscle contraction GO:0006936 INCREASED

Used by disorders

REM Sleep Behavior Disorder as Dream Enactment Behaviour

Downstream

Injury Risk and Prodromal Neurodegeneration Enacted behaviour causes injury; and where the trigger lesion is degenerative, the same pathology progresses to involve nigral and cortical structures.

Injury Risk and Prodromal Neurodegeneration

consequence

Two consequences that must be kept apart. The first is immediate and mechanical: sleep-related injury to patient and bed partner, which is what treatment addresses. The second follows only from the degenerative route and is of a different kind - the pontine lesion is an early stage of a synucleinopathy whose later stages are Parkinson disease, dementia with Lewy bodies, or multiple system atrophy, so the parasomnia is a prodromal marker with a long lead time. Conversion is high but neither immediate nor universal, and the numbers matter: roughly 6% per year, with about three-quarters converting over twelve years. A conforming entry whose trigger is pharmacological or lesional should NOT inherit this second consequence.